Eltrombopag is an effective treatment for patients with chronic idiopathic thrombocytopenic purpura

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1544, 2006-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura: A NICE Single Technology Appraisal

By Boyers Dwayne

PharmacoEconomics, Vol. 30, Iss. 6, 2012-06 ,pp. : 483-495

Adis International

Access to resources Recommend Favorite

Eltrombopag: a guide to its use in chronic immune (idiopathic) thrombocytopenic purpura

Drugs & Therapy Perspectives, Vol. 27, Iss. 2, 2011-02 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Refractory Idiopathic Immune Thrombocytopenic Purpura in Children: Current and Future Treatment Options

By Imbach P.

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 795-801

Adis International

Access to resources Recommend Favorite

Dexamethasone effective in immune thrombocytopenic purpura

Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Emerging drugs for idiopathic thrombocytopenic purpura in adults

By Li Xiaofang Hou Ming

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 237-254

Informa Healthcare

Access to resources Recommend Favorite